Cure My Disease

Don't miss your cure!

 Log in / Sign up

Growth hormone treatment under Long-Term watch in thousands of children

NCT ID NCT04798690

Recruiting now Knowledge-focused Sponsor: Dong-A ST Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tracks the long-term safety and effectiveness of the growth hormone treatment Growtropin-II in children with short stature. It includes up to 5,000 children with growth hormone deficiency, idiopathic short stature, Turner syndrome, or those born small for gestational age. Researchers will monitor side effects and changes in height over time to see how well the treatment works in real-world use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a growth hormone treatment called Growtropin-II
What this could lead to
If successful, this study could confirm the long-term safety and effectiveness of Growtropin-II for helping children with short stature reach a taller final height.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It does not test a new treatment, only monitors existing use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GROWTH HORMONE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fetal growth restriction isolated congenital growth hormone deficiency isolated short stature pituitary dwarfism Turner syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GROWTH HORMONE DEFICIENCY IDIOPATHIC SHORT STATURE SMALL FOR GESTATIONAL AGE TURNER SYNDROME

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yonsei University Health System, Severance Hospital

    RECRUITING

    Seoul, Seodaemun-gu, 03722, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.